What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Toxoplasma gondii in Wildlife: Seroprevalence Studies, Conservation Implications, and One Health Perspectives

Introduction

Toxoplasma gondii is an obligate intracellular apicomplexan parasite with a complex life cycle involving felids as definitive hosts and a wide range of warm-blooded vertebrates as intermediate hosts. The parasite exists in three infectious stages: tachyzoites (rapidly dividing), bradyzoites (encysted in tissues), and sporozoites (within oocysts shed by felids). Wildlife species serve as both sentinels and reservoirs for T. gondii, and seroprevalence surveys provide critical data on environmental contamination, spatial distribution of strains, and potential spillover to domestic animals and humans. This article reviews serological and molecular detection methods, summarizes seroprevalence findings across wild mammals and birds, discusses conservation implications for endangered populations, and frames the issue within a One Health context that links wildlife, domestic animal, and environmental health.

Serological and Molecular Detection Methods

Serological Assays

Seroprevalence studies rely on detection of anti-T. gondii immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies. The modified agglutination test (MAT) is considered the gold standard for wildlife serology because it does not require species-specific secondary antibodies and performs well across diverse taxa [1, 2]. MAT uses formalin-fixed whole tachyzoites and detects IgG and IgM without differentiating isotypes. Sensitivity and specificity exceed 90% in most validation studies [3].

Enzyme-linked immunosorbent assays (ELISAs) are also widely used, often employing crude or recombinant T. gondii antigens (e.g., SAG1, GRA7). Commercial ELISA kits designed for domestic cats or pigs are frequently adapted for wildlife after validation against MAT [4]. However, cross-reactivity with other apicomplexans (e.g., Neospora caninum, Hammondia spp.) can occur, necessitating confirmatory testing [5]. The Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus illustrates the general principle of antigen capture, though the target differs.

Indirect fluorescent antibody tests (IFAT) are used in some laboratories but require species-specific anti-IgG conjugates, limiting their utility in non-model wildlife [6]. Western blotting provides confirmatory evidence but is labor-intensive and rarely applied in large-scale surveys.

Molecular Detection

Polymerase chain reaction (PCR) targeting the 529 bp repetitive element (REP-529) or the B1 gene offers high sensitivity for detecting T. gondii DNA in tissues, blood, or feces [7, 8]. Quantitative real-time PCR (qPCR) allows estimation of parasite burden. Nested PCR and loop-mediated isothermal amplification (LAMP) have been developed for field-deployable detection [9]. Genotyping via multilocus PCR-restriction fragment length polymorphism (RFLP) using markers such as SAG1, SAG2, SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1, and Apico enables strain typing and identification of clonal lineages (Types I, II, III) and atypical genotypes [10, 11].

Diagnostic Workflow

The following Mermaid diagram illustrates a typical diagnostic workflow for T. gondii detection in wildlife samples.

flowchart TD
    A[Wildlife Sample: Serum, Tissue, Feces], > B{Serology}
    B, > C[MAT or ELISA]
    C, > D[Positive]
    C, > E[Negative]
    D, > F[Confirmatory PCR on tissue/blood]
    E, > G[No further testing]
    F, > H[Genotyping by multilocus PCR-RFLP]
    H, > I[Strain identification]
    F, > J[Quantification by qPCR]

Seroprevalence in Wild Mammals

Terrestrial Carnivores

Felids are definitive hosts and often show high seroprevalence. In wild felids such as bobcats (Lynx rufus), pumas (Puma concolor), and European wildcats (Felis silvestris), seroprevalence ranges from 30% to 80% depending on geographic region and prey availability [12, 13]. Canids, including gray wolves (Canis lupus) and red foxes (Vulpes vulpes), serve as sentinels for environmental oocyst contamination. Seroprevalence in wolves in North America ranges from 10% to 60%, with higher rates in areas with high felid density [14, 15].

Marine Mammals

T. gondii infection in marine mammals is a significant conservation concern. Seroprevalence in sea otters (Enhydra lutris) along the California coast reaches 70% in some populations, with acute toxoplasmosis contributing to mortality [16, 17]. The parasite is also detected in harbor seals (Phoca vitulina), California sea lions (Zalophus californianus), and cetaceans [18, 19]. Freshwater runoff carrying oocysts from felid feces is the primary route of exposure [20].

Ungulates and Lagomorphs

Wild ungulates such as white-tailed deer (Odocoileus virginianus) and moose (Alces alces) show variable seroprevalence (10% to 50%) and are important intermediate hosts [21, 22]. European brown hares (Lepus europaeus) and rabbits (Oryctolagus cuniculus) exhibit high seroprevalence in some regions, serving as prey for felids and completing the sylvatic cycle [23].

Rodents and Small Mammals

Rodents are key intermediate hosts. Seroprevalence in wild rats (Rattus norvegicus) and mice (Mus musculus) ranges from 5% to 30% [24, 25]. Infected rodents exhibit altered behavior, including reduced neophobia, which increases predation risk by felids and facilitates parasite transmission [26].

Seroprevalence in Wild Birds

Birds are competent intermediate hosts. Seroprevalence in waterfowl, including mallards (Anas platyrhynchos) and Canada geese (Branta canadensis), ranges from 5% to 40% [27, 28]. Raptors such as red-tailed hawks (Buteo jamaicensis) and great horned owls (Bubo virginianus) show higher seroprevalence (20% to 60%) due to their carnivorous diet [29]. Passerines and corvids also harbor infections, though seroprevalence is generally lower [30]. The role of birds in dispersing T. gondii over long distances is increasingly recognized [31].

Conservation Implications

Endangered Species

T. gondii poses a direct threat to several endangered species. The Hawaiian monk seal (Neomonachus schauinslandi) has experienced fatal toxoplasmosis, with seroprevalence exceeding 50% in some populations [32]. The southern sea otter, listed as threatened under the U.S. Endangered Species Act, suffers from toxoplasmic encephalitis as a leading cause of death [33]. In New Zealand, the endangered kakapo (Strigops habroptilus) and other native birds have succumbed to acute toxoplasmosis after exposure to oocysts from feral cats [34].

Population-Level Effects

Chronic infection can reduce reproductive success and survival. In wild felids, toxoplasmosis may cause abortion or neonatal mortality, though data are limited [35]. In marine mammals, infection is associated with increased risk of predation by sharks and orcas due to neurologic impairment [36]. Population viability analyses for sea otters indicate that toxoplasmosis mortality can reduce population growth rates by 2% to 5% annually [37].

Management Strategies

Conservation interventions include reducing feral cat populations near sensitive habitats, managing oocyst-contaminated runoff, and vaccinating captive endangered species. A live-attenuated T. gondii vaccine (S48 strain) is used in sheep but has not been approved for wildlife [38]. Habitat restoration and public education on responsible cat ownership are critical non-pharmaceutical measures.

One Health Perspectives

Transmission Pathways

The One Health framework integrates human, animal, and environmental health. T. gondii exemplifies this paradigm because oocysts shed by wild and domestic felids contaminate soil and water, infecting wildlife, livestock, and humans. Wild game consumption is a source of human infection in communities that rely on hunting [39]. The Tick-Borne Parasites in White-Tailed Deer article similarly highlights wildlife-livestock interfaces.

Spillover to Domestic Animals

Free-ranging domestic cats that hunt infected rodents or birds amplify environmental contamination. Seroprevalence in feral cats often exceeds 60% [40]. Livestock, particularly pigs and sheep, can acquire infection from oocysts in feed or pasture, leading to economic losses from abortion and stillbirth [41]. The Bovine Neosporosis article discusses a related apicomplexan with similar reproductive impacts.

Environmental Surveillance

Detection of T. gondii oocysts in water and soil using molecular methods (e.g., qPCR targeting REP-529) informs risk assessment [42]. Oocysts are resistant to environmental degradation and can remain infectious for over a year in moist soil [43]. Coastal runoff monitoring is particularly important for marine mammal conservation.

Genomic Epidemiology

Whole-genome sequencing of T. gondii isolates from wildlife reveals population structure and transmission networks. Atypical genotypes are more common in South America and are associated with severe disease in humans and animals [44]. In North America and Europe, clonal Types II and III predominate in wildlife [45]. Comparative genomics identifies virulence determinants such as ROP18 and ROP5 [46].

Computational Modeling

Spatial and mathematical models predict infection risk based on felid density, land use, and climate. Machine learning algorithms trained on seroprevalence data can identify high-risk areas for conservation planning [47]. The Biological Foundation Models for Veterinary Virology article discusses similar predictive approaches for viral pathogens.

Conclusion

Toxoplasma gondii is a pervasive parasite in wildlife populations worldwide. Seroprevalence studies using MAT, ELISA, and PCR provide essential data on exposure patterns and strain diversity. Conservation implications are profound for endangered species such as sea otters, monk seals, and island birds. A One Health approach that integrates wildlife surveillance, domestic cat management, and environmental monitoring is necessary to mitigate the impact of toxoplasmosis on biodiversity and public health. Future research should focus on developing wildlife-safe vaccines, improving field-deployable diagnostics, and expanding genomic surveillance across understudied regions.

References

[1] Dubey JP. Toxoplasmosis of animals and humans. 2nd ed. CRC Press; 2010.

[2] Dubey JP, Desmonts G. Serological responses of equids fed Toxoplasma gondii oocysts. Equine Vet J. 1987;19(4):337-339.

[3] Dubey JP, Thuilliez P, Weigel RM, et al. Sensitivity and specificity of various serologic tests for detection of Toxoplasma gondii infection in cats. J Am Vet Med Assoc. 1995;207(9):1185-1188.

[4] Gamble HR, Dubey JP, Lambillotte DN. Comparison of a commercial ELISA with the modified agglutination test for detection of Toxoplasma gondii antibodies in sheep sera. J Parasitol. 2000;86(4):842-844.

[5] Gondim LFP, McAllister MM, Mateus-Pinilla NE, et al. Transmission of Neospora caninum between wild and domestic animals. J Parasitol. 2004;90(6):1361-1365.

[6] Hill DE, Chirukandoth S, Dubey JP, et al. Comparison of detection methods for Toxoplasma gondii in naturally exposed swine. J Parasitol. 2006;92(5):1028-1032.

[7] Homan WL, Vercammen M, De Braekeleer J, et al. Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR. Int J Parasitol. 2000;30(1):69-75.

[8] Burg JL, Grover CM, Pouletty P, et al. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol. 1989;27(8):1787-1792.

[9] Lau YL, Meganathan P, Sonaimuthu P, et al. Specific, sensitive, and rapid diagnosis of active toxoplasmosis by a loop-mediated isothermal amplification method using blood samples from patients. J Clin Microbiol. 2010;48(10):3698-3702.

[10] Su C, Zhang X, Dubey JP. Genotyping of Toxoplasma gondii by multilocus PCR-RFLP markers: a high resolution and simple method for identification of parasites. Int J Parasitol. 2006;36(7):841-848.

[11] Khan A, Taylor S, Su C, et al. Composite genome map and recombination parameters derived from three archetypal lineages of Toxoplasma gondii. Nucleic Acids Res. 2005;33(9):2980-2992.

[12] Riley SPD, Foley J, Chomel B. Exposure to feline and canine pathogens in bobcats and gray foxes in urban and rural zones of a national park in California. J Wildl Dis. 2004;40(1):11-22.

[13] Gauss CBL, Dubey JP, Vidal D, et al. Seroprevalence of Toxoplasma gondii in wild carnivores from Spain. Vet Parasitol. 2006;138(3-4):265-270.

[14] Zarnke RL, Dubey JP, Kwok OCH, et al. Serologic survey for Toxoplasma gondii in selected wildlife species from Alaska. J Wildl Dis. 2001;37(2):296-300.

[15] Antolová D, Reiterová K, Dubinský P. Seroprevalence of Toxoplasma gondii in wild boars, red deer, and roe deer in Slovakia. Ann Agric Environ Med. 2007;14(1):71-74.

[16] Conrad PA, Miller MA, Kreuder C, et al. Transmission of Toxoplasma gondii from land to sea: evidence from sea otters. Int J Parasitol. 2005;35(11-12):1155-1168.

[17] Miller MA, Gardner IA, Kreuder C, et al. Coastal freshwater runoff is a risk factor for Toxoplasma gondii infection of southern sea otters (Enhydra lutris nereis). Int J Parasitol. 2002;32(8):997-1006.

[18] Dubey JP, Zarnke R, Thomas NJ, et al. Toxoplasma gondii, Neospora caninum, Sarcocystis neurona, and Sarcocystis canis-like infections in marine mammals. Vet Parasitol. 2003;116(4):275-296.

[19] Mazzariol S, Marcer F, Mignone W, et al. Dolphin morbillivirus and Toxoplasma gondii coinfection in a Mediterranean fin whale (Balaenoptera physalus). BMC Vet Res. 2012;8:20.

[20] VanWormer E, Conrad PA, Miller MA, et al. Toxoplasma gondii, source to sea: higher contribution of domestic felids to terrestrial parasite loading than galapagos felids. Ecohealth. 2013;10(4):389-401.

[21] Dubey JP, Humphreys JG, Thulliez P. Prevalence of Toxoplasma gondii infection in white-tailed deer (Odocoileus virginianus) in the northeastern United States. J Parasitol. 1995;81(2):282-284.

[22] Vikøren T, Tharaldsen J, Fredriksen B, et al. Prevalence of Toxoplasma gondii antibodies in wild red deer, roe deer, and moose in Norway. J Wildl Dis. 2004;40(3):548-552.

[23] Almería S, Calvete C, Pagés A, et al. Factors affecting the seroprevalence of Toxoplasma gondii infection in wild rabbits (Oryctolagus cuniculus) from Spain. Vet Parasitol. 2004;123(3-4):265-270.

[24] Webster JP. Prevalence and transmission of Toxoplasma gondii in wild brown rats, Rattus norvegicus. Parasitology. 1994;108(4):407-411.

[25] Afonso E, Thulliez P, Gilot-Fromont E. Transmission of Toxoplasma gondii in an urban population of domestic cats (Felis catus). Int J Parasitol. 2006;36(13):1373-1382.

[26] Berdoy M, Webster JP, Macdonald DW. Fatal attraction in rats infected with Toxoplasma gondii. Proc Biol Sci. 2000;267(1452):1591-1594.

[27] Dubey JP. Toxoplasma gondii infections in chickens (Gallus domesticus): prevalence, clinical disease, diagnosis, and public health significance. Zoonoses Public Health. 2010;57(1):60-73.

[28] Elmore SA, Jones JL, Conrad PA, et al. Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends Parasitol. 2010;26(4):190-196.

[29] Lindsay DS, Dubey JP. Toxoplasma gondii in wild birds. J Parasitol. 2009;95(6):1271-1273.

[30] Molina-López RA, Cabezón O, Pabón M, et al. High seroprevalence of Toxoplasma gondii and Neospora caninum in the common raven (Corvus corax) in the Northeast of Spain. Res Vet Sci. 2012;93(1):300-302.

[31] Prestrud KW, Dubey JP, Asbakk K, et al. First isolate of Toxoplasma gondii from arctic fox (Vulpes lagopus) from Svalbard. Vet Parasitol. 2008;151(2-4):110-114.

[32] Honnold SP, Braun R, Scott DP, et al. Toxoplasmosis in a Hawaiian monk seal (Monachus schauinslandi). J Parasitol. 2005;91(3):695-697.

[33] Kreuder C, Miller MA, Jessup DA, et al. Patterns of mortality in southern sea otters (Enhydra lutris nereis) from 1998-2001. J Wildl Dis. 2003;39(3):495-509.

[34] Howe L, Hunter S, Burrows E, et al. Four cases of fatal toxoplasmosis in three species of endemic New Zealand birds. Avian Dis. 2012;56(4):783-786.

[35] Brown M, Lappin MR, Brown JL, et al. Seroprevalence of Toxoplasma gondii in wild felids from the United States. J Wildl Dis. 2005;41(3):589-594.

[36] Miller MA, Conrad PA, Harris M, et al. A protozoal-associated epizootic in marine mammals: Toxoplasma gondii infection in southern sea otters (Enhydra lutris nereis). J Parasitol. 2001;87(6):1295-1302.

[37] Tinker MT, Hatfield BB, Harris MD, et al. Dramatic increase in sea otter mortality from white sharks in California. Mar Mamm Sci. 2016;32(1):309-326.

[38] Buxton D, Innes EA. A commercial vaccine for ovine toxoplasmosis. Parasitology. 1995;110(Suppl):S11-S16.

[39] Jones JL, Dubey JP. Foodborne toxoplasmosis. Clin Infect Dis. 2012;55(6):845-851.

[40] Dabritz HA, Conrad PA. Cats and Toxoplasma: implications for public health. Zoonoses Public Health. 2010;57(1):34-52.

[41] Dubey JP. Toxoplasmosis in sheep: a review. Vet Parasitol. 2009;163(1-2):1-14.

[42] Shapiro K, VanWormer E, Aguilar B, et al. Simultaneous detection of Toxoplasma gondii and Cryptosporidium parvum oocysts in water by real-time PCR. Appl Environ Microbiol. 2010;76(13):4280-4286.

[43] Frenkel JK, Dubey JP. Effects of freezing on the viability of Toxoplasma gondii oocysts. J Parasitol. 1973;59(3):587-588.

[44] Khan A, Jordan C, Muccioli C, et al. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg Infect Dis. 2006;12(6):942-949.

[45] Su C, Khan A, Zhou P, et al. Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages. Proc Natl Acad Sci USA. 2012;109(15):5844-5849.

[46] Saeij JPJ, Boyle JP, Coller S, et al. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science. 2006;314(5806):1780-1783.

[47] Gottdenker NL, Streicker DG, Faust CL, et al. Anthropogenic land use change and infectious diseases: a review of the evidence. Ecohealth. 2014;11(4):619-632.

[48] Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol. 2008;38(11):1257-1278.

[49] Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30(12-13):1217-1258.

[50] Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25(2):264-296.